Hemispherx Biopharma’s CEO to Present at Planet MicroCap Showcase 2019

NEXT STORY
Europe IVD Market Is Estimated to Reach $26.6 Billion by 2023: AMR
PREV STORY
Leading BioSciences to Present at Planet MicroCap Showcase 2019
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

electroCore Announces New Patent Expanding Claims Related to Delivery of Non-Invasive Vagus Nerve Stimulation Therapy Using Mobile Devices

author_avatar
NASDAQ Market News

Calithera Biosciences Announces FDA Fast Track Designation Granted to CB-839 in Combination with Cabozantinib for Treatment of Patients with Advanced Renal Cell Carcinoma

author_avatar
NASDAQ Market News

Roche’s Actemra/RoActemra becomes the first biologic therapy approved by the FDA for slowing the rate of decline in pulmonary function in adults with systemic sclerosis-associated interstitial lung disease, a rare, debilitating condition

author_avatar
NASDAQ Market News